Canadians spent approximately $33 billion on prescribed drugs in 2018*, with more than half being paid by private companies and individuals.
Are you doing all you can to manage costs for your workforce?
*Canadian Institute for Health Information
Pharmacy Benefits Management
Across Canada, provinces are starting to support the switch from biologic drugs to biosimilar drugs, which are clinically similar, but considerably less expensive.Learn More
When it comes to benefit plan sustainability, the main challenge continues to be rising prescription costs, including specialty drugs.Learn More
Plan administrators and formulary experts may say “no” or “not yet” to certain new cancer treatments. Learn more about how to manage claims of newer specialty drugs.Learn More